Mars Bioimaging
Christchurch
About Mars Bioimaging
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $15.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
- Website: marsbioimaging.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/mars-bioimaging-53590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.